Lars Johansson Selected Research

Lipids

4/2020	Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population.
12/2019	Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial.
1/2015	The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Johansson Research Topics

Disease

14	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2008
14	Body Weight (Weight, Body) 01/2022 - 10/2002
9	Neoplasms (Cancer) 11/2020 - 09/2003
9	Myocardial Infarction 02/2017 - 01/2002
8	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2018
8	Stroke (Strokes) 03/2021 - 08/2005
7	Hemorrhage 12/2016 - 06/2007
6	Obesity 04/2020 - 04/2004
5	Cerebral Hemorrhage 11/2020 - 04/2004
5	Ischemic Stroke 01/2017 - 08/2005
4	Cicatrix (Scar) 02/2017 - 07/2009
3	Weight Loss (Weight Reduction) 01/2022 - 01/2011
3	Fatty Liver 11/2021 - 12/2019
3	Hypertension (High Blood Pressure) 01/2020 - 01/2017
3	Insulin Resistance 01/2019 - 12/2008
3	Hemorrhagic Stroke 01/2017 - 02/2002
3	Atrial Fibrillation 12/2016 - 10/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 01/2010
3	Inflammation (Inflammations) 06/2014 - 12/2008
3	Myocardial Ischemia (Ischemic Heart Diseases) 08/2004 - 08/2002
2	Overweight 12/2019 - 11/2018
2	Heart Failure 01/2019 - 05/2011
2	Infarction (Infarctions) 03/2017 - 02/2015
2	Infections 03/2016 - 03/2012
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016 - 05/2012
2	Death (Near-Death Experience) 01/2016 - 05/2013
2	Insulinoma 07/2014 - 05/2014
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2014 - 01/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2014 - 05/2008
2	Atherosclerosis 12/2012 - 10/2007
2	Coronary Disease (Coronary Heart Disease) 10/2007 - 03/2006
2	Coronary Occlusion 07/2006 - 08/2004
1	Fibrosis (Cirrhosis) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 11/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2020

Drug/Important Bio-Agent (IBA)

10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2012
7	AnticoagulantsIBA 01/2017 - 07/2009
6	dapagliflozinIBA 01/2022 - 03/2012
6	EnzymesIBA 11/2021 - 12/2012
6	Warfarin (Coumadin)FDA LinkGeneric 12/2016 - 06/2007
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2014
5	von Willebrand FactorIBA 11/2020 - 02/2002
5	Blood Glucose (Blood Sugar)IBA 03/2017 - 06/2010
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 05/2014
4	Protons (Proton)IBA 01/2022 - 04/2020
4	Glucagon-Like Peptide-1 ReceptorIBA 01/2021 - 05/2014
4	CholesterolIBA 01/2018 - 06/2014
4	GadoliniumIBA 02/2017 - 07/2006
4	Tryptophan (L-Tryptophan)FDA Link 01/2017 - 05/2014
4	C-Reactive ProteinIBA 02/2015 - 10/2007
4	Contrast MediaIBA 07/2006 - 10/2002
3	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 03/2012
3	Triglycerides (Triacylglycerol)IBA 04/2020 - 12/2012
3	LipidsIBA 04/2020 - 01/2015
3	Dihydroorotate DehydrogenaseIBA 01/2020 - 01/2018
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019 - 03/2012
3	Insulin (Novolin)FDA Link 12/2018 - 06/2010
3	AntigensIBA 11/2015 - 07/2009
3	Troponin IIBA 02/2015 - 05/2011
3	Exenatide (Byetta)FDA Link 01/2015 - 05/2014
3	manganese chloride (manganese chloride, tetrahydrate)FDA Link 04/2014 - 05/2004
3	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2012 - 01/2002
3	ThrombomodulinIBA 07/2009 - 02/2002
3	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 08/2004 - 10/2002
2	glimepiride (Amarel)FDA LinkGeneric 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2022 - 11/2020
2	saxagliptin FDA Link 01/2022 - 01/2020
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2021 - 07/2014
2	Factor XII (Hageman Factor)IBA 03/2021 - 01/2017
2	Glucagon Receptors (Glucagon Receptor)IBA 01/2021 - 10/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2019 - 03/2006
2	Sodium-Glucose Transport ProteinsIBA 01/2019 - 03/2012
2	Carboxylic AcidsIBA 11/2018 - 01/2018
2	fibrin fragment D (D-dimer)IBA 01/2018 - 05/2014
2	LDL CholesterolIBA 03/2017 - 06/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2017 - 12/2012
2	omega-Chloroacetophenone (Mace)IBA 01/2016 - 05/2013
2	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2015 - 05/2011
2	Cystatin CIBA 02/2015 - 08/2013
2	pro-brain natriuretic peptide (1-76)IBA 02/2015 - 05/2011
2	Parathyroid Hormone (Parathormone)IBA 11/2014 - 07/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2014 - 01/2007
2	N,N'- bis(pyridoxal- 5- phosphate)ethylenediamine- N,N'- diacetic acid (mangafodipir)FDA Link 04/2014 - 05/2004
2	Plasminogen Activators (Plasminogen Activator)IBA 12/2012 - 08/2005
2	Lipoproteins (Lipoprotein)IBA 12/2012 - 05/2012
2	IronIBA 01/2007 - 10/2002
1	Glucagon (Glukagon)FDA Link 01/2022
1	IncretinsIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	semaglutideIBA 11/2021
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2021
1	omega-3 carboxylic acidIBA 01/2021
1	NucleotidesIBA 11/2020
1	ABO Blood-Group SystemIBA 11/2020
1	Phosphotransferases (Kinase)IBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 11/2020

Therapy/Procedure

4	Therapeutics 10/2020 - 01/2018
3	Glycemic Control 01/2022 - 03/2012
2	Drug Therapy (Chemotherapy) 11/2020 - 09/2003